New Edge Advisors, LLC Exact Sciences Corp Transaction History

New Edge Advisors, LLC

  • $16.2 Billion
  • Q1 2025

A detailed history of New Edge Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, New Edge Advisors, LLC holds 723 shares of EXAS stock, worth $34,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
723
Previous 3,989 81.88%
Holding current value
$34,371
Previous $224,000 86.16%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$43.04 - $58.51 $140,568 - $191,093
-3,266 Reduced 81.88%
723 $31,000
Q4 2024

Feb 13, 2025
SELL
$49.33 - $71.97 $390,249 - $569,354
-7,911 Reduced 66.48%
3,989 $224,000
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $404,018 - $674,443
9,522 Added 400.42%
11,900 $810,000
Q2 2024

Aug 15, 2024
SELL
$41.33 - $74.26 $178,338 - $320,431
-4,315 Reduced 64.47%
2,378 $100,000
Q1 2024

May 14, 2024
SELL
$56.27 - $73.77 $38,151 - $50,016
-678 Reduced 9.2%
6,693 $462,000
Q4 2023

Feb 13, 2024
SELL
$59.06 - $75.72 $9,449 - $12,115
-160 Reduced 2.12%
7,371 $545,000
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $54,730 - $82,203
-830 Reduced 9.93%
7,531 $513,000
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $44,001 - $66,725
702 Added 9.17%
8,361 $785,000
Q1 2023

May 12, 2023
SELL
$47.19 - $70.77 $49,455 - $74,166
-1,048 Reduced 12.04%
7,659 $519,000
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $64,129 - $112,305
-2,113 Reduced 19.53%
8,707 $431,000
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $345,915 - $534,183
10,820 New
10,820 $352,000
Q4 2021

Feb 17, 2022
SELL
$72.5 - $100.68 $164,865 - $228,946
-2,274 Closed
0 $0
Q3 2021

Oct 29, 2021
SELL
$90.24 - $124.05 $14,979 - $20,592
-166 Reduced 6.8%
2,274 $217,000
Q2 2021

Jul 22, 2021
BUY
$93.66 - $139.27 $13,018 - $19,358
139 Added 6.04%
2,440 $303,000
Q1 2021

Apr 26, 2021
BUY
$116.57 - $155.01 $268,227 - $356,678
2,301 New
2,301 $303,000
Q4 2020

Jan 27, 2021
SELL
$99.61 - $142.12 $473,047 - $674,927
-4,749 Closed
0 $0
Q3 2020

Nov 03, 2020
BUY
$72.92 - $102.01 $346,297 - $484,445
4,749 New
4,749 $484,000
Q2 2020

Jul 29, 2020
SELL
$55.75 - $92.75 $399,950 - $665,388
-7,174 Closed
0 $0
Q1 2020

May 04, 2020
BUY
$37.9 - $104.44 $271,894 - $749,252
7,174 New
7,174 $416,000
Q4 2018

Jan 29, 2019
SELL
$56.04 - $82.66 $158,032 - $233,101
-2,820 Closed
0 $0
Q3 2018

Oct 29, 2018
BUY
$48.29 - $80.6 $136,177 - $227,291
2,820 New
2,820 $223,000

Others Institutions Holding EXAS

# of Institutions
638
Shares Held
156M
Call Options Held
1.64M
Put Options Held
1.5M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.41B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email